Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 239-246

  Xu, Bing ^a   Hamada, Shinshichi ^a   Kusuki, Izumi ^a   Itoh, Ryoji ^b   Kitawaki, Jo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO FIRST RED CROSS HOSPITAL   (Japan)

Author keywords

Loss of heterozygosity; Malignant transformation; Mutation; Ovarian cancer arising from endometriosis

Indexed keywords

FLUORESCENT DYE; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADULT; ARTICLE; CANCER CELL; CANCER TISSUE; CELL CLONE; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 9P; CLINICAL ARTICLE; DNA EXTRACTION; DNA SEQUENCE; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MICRODISSECTION; MICROSATELLITE MARKER; MUTATION RATE; OVARY CANCER; OVARY ENDOMETRIOSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA, CLEAR CELL; ADULT; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; FEMALE; GENES, P53; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PTEN PHOSPHOHYDROLASE; YOUNG ADULT;

EID: 79251596427     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.036     Document Type: Article

References (32)

1. B. Eskenazi, and M.L. Warner Epidemiology of endometriosis Obstet. Gynecol. Clin. North Am. 24 1997 235 258
2. D.L. Olive Medical therapy of endometriosis Semin. Reprod. Med. 21 2003 209 222
3. L.A. Brinton, G. Gridley, I. Persson, J. Baron, and A. Bergqvist Cancer risk after a hospital discharge diagnosis of endometriosis Am. J. Obstet. Gynecol. 176 1997 572 579
4. H. Kobayashi, K. Sumimoto, N. Moniwa, M. Imai, K. Takakura, and T. Kuromaki Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan Int. J. Gynecol. Cancer 17 2007 37 43
5. Aris A. Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res 2010;19:3:2.
6. A. Melin, P. Sparén, I. Persson, and A. Bergqvist Endometriosis and the risk of cancer with special emphasis on ovarian cancer Hum. Reprod. 21 2006 1237 1242
7. J.D. Seidman Prognostic importance of hyperplasia and atypia in endometriosis Int. J. Gynecol. Pathol. 15 1996 1 9
8. R.C. Stern, R. Dash, R.C. Bentley, M.J. Snyder, A.F. Haney, and S.J. Robboy Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types Int. J. Gynecol. Pathol. 20 2001 133 139
9. M. Erzen, and J. Kovacic Relationship between endometriosis and ovarian cancer Eur. J. Gynaec. Oncol. 19 1998 553 555
10. M. Fukunaga, K. Nomura, E. Ishikawa, and S. Ushigome Ovarian atypical endometriosis: its close association with malignant epithelial tumours Histopathology 30 1997 249 255
11. P. Vercellini, F. Parazzini, G. Bolis, S. Carinelli, M. Dindelli, and N. Vendola Endometriosis and ovarian cancer Am. J. Obstet. Gynecol. 169 1993 181 182
12. S.C. Modesitt, G. Tortolero-Luna, J.B. Robinson, D.M. Gershenson, and J.K. Wolf Ovarian and extraovarian endometriosis-associated cancer Obstet. Gynecol. 100 2002 788 795
13. P. Viganó, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis Hum. Reprod. Update 12 2006 77 89
14. M. Nishida, K. Watanabe, N. Sato, and Y. Ichikawa Malignant transformation of ovarian endometriosis Gynecol. Obstet. Invest. 50 Suppl 1 2000 18 25
15. J.A. Sampson Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ Arch. Surg. 10 1925 1 72
16. R.B. Scott Malignant changes in endometriosis Obstet. Gynecol. 2 1953 283 289
17. G. Kristiansen, C. Pilarsky, C. Wissmann, S. Kaiser, T. Bruemmendorf, and S. Roepcke Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival J. Pathol. 205 2005 359 376
18. A. Sigal, and V. Rotter Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome Cancer Res. 60 2000 6788 6793
19. T. Lasky, and E. Silbergeld P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers Environ. Health Perspect. 104 1996 1324 1331
20. M. Akbari, M.D. Hansen, J. Halgunset, F. Skorpen, and H.E. Krokan Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner J. Mol. Diagn. 7 2005 36 39
21. X. Jiang, A. Hitchcock, E.J. Bryan, R.H. Watson, P. Englefield, and E.J. Thomas Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci Cancer Res. 56 1996 3534 3539
22. X. Jiang, S.J. Morland, A. Hitchcock, E.J. Thomas, and I.G. Campbell Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage Cancer Res. 58 1998 1707 1712
23. N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, and T. Kubo Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary Cancer Res. 60 2000 7052 7056
24. R. Ali-Fehmi, I. Khalifeh, S. Bandyopadhyay, W.D. Lawrence, E. Silva, and D. Liao Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis Int. J. Gynecol. Pathol. 25 2006 223 229
25. A.H. Prowse, S. Manek, R. Varma, J. Liu, A.K. Godwin, and E.R. Maher Molecular genetic evidence that endometriosis is a precursor of ovarian cancer Int. J. Cancer 119 2006 556 562
26. G.L. Mutter, M.C. Lin, J.T. Fitzgerald, J.B. Kum, J.P. Baak, and J.A. Lees Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers J. Natl Cancer Inst. 92 2000 924 930
27. K. Obata, and H. Hoshiai Common genetic changes between endometriosis and ovarian cancer Gynecol. Obstet. Invest. 50 Suppl 1 2000 39 43
28. D.M. Dinulescu, T.A. Ince, B.J. Quade, S.A. Shafer, D. Crowley, and T. Jacks Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer Nat. Med. 11 2005 63 70
29. T. Akahane, A. Sekizawa, Y. Purwosunu, M. Nagatsuka, and T. Okai The role of p53 mutation in the carcinomas arising from endometriosis Int. J. Gynecol. Pathol. 26 2007 345 351
30. J. Otsuka, T. Okuda, A. Sekizawa, S. Amemiya, H. Saito, and T. Okai K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma Med. Electron Microsc. 37 2004 188 192
31. S. Amemiya, A. Sekizawa, J. Otsuka, T. Tachikawa, H. Saito, and T. Okai Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability Int. J. Gynaecol. Obstet. 86 2004 371 376
32. F.H. van Nederveen, A. Perren, H. Dannenberg, B.J. Petri, W.N. Dinjens, P. Komminoth, and R.R. de Krijger PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas J. Pathol. 209 2006 274 280